As of Jun 24
| -3.03 / -9.00%|
The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 75.00, with a high estimate of 89.00 and a low estimate of 36.00. The median estimate represents a +144.94% increase from the last price of 30.62.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.